Funder
Japan Society of Clinical Oncology
Janssen Pharmaceutical K.K.
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Hematology,General Medicine,Surgery
Reference28 articles.
1. Howlader N, Noone AM, Krapcho M, et al. SEER Cancer statistics review, 1975–2014, National Cancer Institute. Bethesda, MD,
https://seer.cancer.gov/csr/1975_2014/
. Based on November 2016 SEER data submission, posted to the SEER web site, April 2017
2. Center for cancer control and information services, National Cancer center, Japan
https://ganjoho.jp/reg_stat/statistics/stat/summary.html
. Accessed 22 May 2019
3. Jayson GC, Kohn EC, Kitchener HC et al (2014) Ovarian cancer. Lancet 384:1376–1388
4. Grunewald T, Ledermann JA (2017) Targeted therapies for ovarian cancer. Best Pract Res Clin Obstet Gynaecol 41:139–152
5. Aghajanian C, Goff B, Nycum LR et al (2015) Final overall survival and safety analysis of OCEANS, a phase 3 trial of chemotherapy with or without bevacizumab in patients with platinum-sensitive recurrent ovarian cancer. Gynecol Oncol 139:10–16
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献